Joy Gumin

7.8k total citations · 1 hit paper
74 papers, 3.7k citations indexed

About

Joy Gumin is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Joy Gumin has authored 74 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 28 papers in Genetics and 26 papers in Oncology. Recurrent topics in Joy Gumin's work include Virus-based gene therapy research (19 papers), Glioma Diagnosis and Treatment (18 papers) and Mesenchymal stem cell research (13 papers). Joy Gumin is often cited by papers focused on Virus-based gene therapy research (19 papers), Glioma Diagnosis and Treatment (18 papers) and Mesenchymal stem cell research (13 papers). Joy Gumin collaborates with scholars based in United States, Spain and Japan. Joy Gumin's co-authors include Frederick F. Lang, Frank C. Marini, Michael Andreeff, Giacomo G. Vecil, Juàn Fueyo, Akira Nakamizo, Toshiyuki Amano, Naoki Shinojima, Julianne Chen and Stephen J. Hentschel and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and PLoS ONE.

In The Last Decade

Joy Gumin

71 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas

2005 869 citations Frank C. Marini, Joy Gumin et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joy Gumin United States	28	1.9k	1.5k	1.2k	1.0k	575	74	3.7k
Erika L. Spaeth United States	18	1.6k 0.8×	1.8k 1.2×	1.9k 1.6×	864 0.8×	395 0.7×	33	4.0k
John Glod United States	25	1.4k 0.7×	1.1k 0.8×	1.3k 1.1×	701 0.7×	207 0.4×	86	3.3k
Mario L. Suvà United States	21	3.2k 1.6×	946 0.6×	947 0.8×	1.4k 1.3×	243 0.4×	47	4.4k
Ajeeta B. Dash United States	11	1.6k 0.8×	1.0k 0.7×	1.8k 1.5×	808 0.8×	169 0.3×	23	3.6k
Scott J. Dylla United States	17	2.5k 1.3×	622 0.4×	2.7k 2.2×	951 0.9×	283 0.5×	36	4.7k
Rintaro Hashizume United States	32	2.9k 1.5×	1.5k 1.0×	746 0.6×	627 0.6×	395 0.7×	91	4.2k
Mizuhiko Terasaki Japan	16	2.2k 1.1×	1.3k 0.9×	2.7k 2.2×	1.1k 1.1×	177 0.3×	47	4.6k
Esther Hulleman Netherlands	28	2.3k 1.2×	1.1k 0.7×	1.1k 0.9×	875 0.8×	186 0.3×	81	3.7k
Kazuhiko Kurozumi Japan	26	1.4k 0.7×	1.3k 0.9×	756 0.6×	399 0.4×	796 1.4×	109	3.1k
Ross Tubo United States	17	1.4k 0.7×	1.1k 0.7×	1.6k 1.3×	759 0.7×	200 0.3×	19	3.7k

Countries citing papers authored by Joy Gumin

Since Specialization

Citations

This map shows the geographic impact of Joy Gumin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Gumin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Gumin more than expected).

Fields of papers citing papers by Joy Gumin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy Gumin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Gumin. The network helps show where Joy Gumin may publish in the future.

Co-authorship network of co-authors of Joy Gumin

This figure shows the co-authorship network connecting the top 25 collaborators of Joy Gumin. A scholar is included among the top collaborators of Joy Gumin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Gumin. Joy Gumin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poon, Candice C., Shelley M. Herbrich, Yulong Chen, et al.. (2025). Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome. Cancer Immunology Research. 13(6). 804–820. 2 indexed citations

Ledbetter, Daniel, Joy Gumin, Lynette Phillips, et al.. (2024). Facilitating Repeat Intracarotid Injections in Mouse Models by a Novel Injection Site Repair Technique. Journal of Visualized Experiments.

Liang, Jiyong, Dexing Fang, Joy Gumin, et al.. (2023). A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin. Cancers. 15(4). 1085–1085. 1 indexed citations

Jiang, Hong, Xuejun Fan, Joy Gumin, et al.. (2023). Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity. Cancer Research Communications. 3(6). 1118–1131. 3 indexed citations

Nguyen, Teresa T., Sanjay K. Singh, Yisel Rivera-Molina, et al.. (2022). Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry. Journal for ImmunoTherapy of Cancer. 10(7). e004935–e004935. 35 indexed citations

Modrek, Aram S., Eskil Eskilsson, Ravesanker Ezhilarasan, et al.. (2022). PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells. Frontiers in Oncology. 12. 941657–941657. 5 indexed citations

Phillips, Lynette M., Shoudong Li, Joy Gumin, et al.. (2021). An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus. Neuro-Oncology. 23(11). 1911–1921. 8 indexed citations

Salzillo, Travis C., Joseph Weygand, Joy Gumin, et al.. (2021). Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance. Cells. 10(10). 2621–2621. 9 indexed citations

Gupta, Sumit, Virginia Laspidea, Juàn Fueyo, et al.. (2021). Abstract 3053: Armed oncolytic virus for treatment of pediatric diffuse intrinsic pontine glioma. Cancer Research. 81(13_Supplement). 3053–3053. 1 indexed citations

10.

Srinivasan, Visish M., Joy Gumin, Melissa Chen, et al.. (2020). Endovascular Selective Intra-Arterial Infusion of Mesenchymal Stem Cells Loaded With Delta-24 in a Canine Model. Neurosurgery. 88(1). E102–E113. 18 indexed citations

11.

Zinn, Pascal O., Sanjay K. Singh, Aikaterini Kotrotsou, et al.. (2018). A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clinical Cancer Research. 24(24). 6288–6299. 80 indexed citations

12.

Lu, Li, Anantha Marisetty, Bin Liu, et al.. (2018). REST overexpression in mice causes deficits in spontaneous locomotion. Scientific Reports. 8(1). 12083–12083. 6 indexed citations

13.

Canella, Alessandro, Alessandra M. Welker, Ji Young Yoo, et al.. (2017). Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas. Clinical Cancer Research. 23(20). 6215–6226. 52 indexed citations

14.

Figueroa, Javier, Lynette M. Phillips, Tal Shahar, et al.. (2017). Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587. Cancer Research. 77(21). 5808–5819. 181 indexed citations

15.

Dai, Bingbing, David Roife, Ya’an Kang, et al.. (2017). Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 16(4). 662–670. 17 indexed citations

16.

Lang, Frederick, Anwar Hossain, Joy Gumin, et al.. (2017). Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas. Neuro-Oncology. 20(3). 380–390. 207 indexed citations

17.

Fahim, Daniel K., Claudio E. Tatsui, Dima Suki, et al.. (2014). Orthotopic murine model of a primary malignant bone tumor in the spine: functional, bioluminescence, and histological correlations. Journal of Neurosurgery Spine. 21(3). 378–385. 1 indexed citations

18.

Shinojima, Naoki, Anwar Hossain, Tatsuya Takezaki, et al.. (2013). TGF-β Mediates Homing of Bone Marrow–Derived Human Mesenchymal Stem Cells to Glioma Stem Cells. Cancer Research. 73(7). 2333–2344. 83 indexed citations

19.

Yong, Raymund L., Naoki Shinojima, Juàn Fueyo, et al.. (2009). Human Bone Marrow–Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Δ24-RGD to Human Gliomas. Cancer Research. 69(23). 8932–8940. 192 indexed citations

20.

Hata, Nobuhiro, Naoki Shinojima, Joy Gumin, et al.. (2009). Platelet-Derived Growth Factor BB Mediates the Tropism of Human Mesenchymal Stem Cells for Malignant Gliomas. Neurosurgery. 66(1). 144–157. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact